European Leukemia Trial Registry
Trial: AML Elderly

More Details
Scientific Title Treatment of Elderly Patients (>60 years) with de novo or Secondary Acute Myeloblastic Leukemia or Advanced MDS (RAEB-T): A Study to test the Efficacy of intensive chemotherapy followed by G-CSF and a Feasability Trial of Dose-reduced Allogeneic Transplantation and of Autologous Stem Cell Transplantation
Short Title AML Elderly
Trialgroup NN
Type of Trial multicentric
Disease Myelodysplastic Syndrome(MDS) All subtypes
Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age >= 60 years
Status Closed
Start of Recruitment 05.01.2000
Leader Ottmann, Prof. Dr., Oliver
Contactperson

Study Physician
Bug, PD Dr. med., Gesine
Tel: +49 (0)69 6301 7369
Fax: +49 (0)69 6301 7463
Email: g.bug@em.uni-frankfurt.de

Study Centre
Zander, Caroline
Tel: +49 (0)69 6301 4802
Fax: +49 (0)69 6301 7463
Email: c.zander@em.uni-frankfurt.de

Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
Diagnostics

Cytogenetics
Institut für Humangenetik, Medizinische Hochschule Hannover (MHH)

created 30.06.2006 Anja Hellenbrecht
changed 28.10.2015 Sina Hehn
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org